| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 17 |
| 1 | OMEPRAZOLE MAGNESIUM | 14 |
| 2 | OMEPRAZOLE | 13 |
| 3 | ADALIMUMAB | 12 |
| 4 | IBUPROFEN | 12 |
| 5 | PREDNISONE | 12 |
| 6 | IBUPFROFEN | 10 |
| 7 | IBUPROFEN 200 MG | 10 |
| 8 | IBUPROFEN 200MG | 10 |
| 9 | IBUPROFEN CAPSULE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARBON DIOXIDE | 1 | 0.0087 |
| 1 | OXACILLIN SODIUM | 6 | 0.0053 |
| 2 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 3 | TERBUTALINE SULFATE | 5 | 0.0027 |
| 4 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 5 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| 6 | ALFUZOSIN HYDROCHLORIDE | 3 | 0.0012 |
| 7 | COAGULATION FACTOR VIIA (RECOMBINANT) | 3 | 0.0011 |
| 8 | CEFTAZIDIME | 5 | 0.0006 |
| 9 | BELANTAMAB MAFODOTIN | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 27 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 2 | Factor Xa Inhibitor [EPC] | 22 |
| 3 | Proton Pump Inhibitor [EPC] | 21 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 12 |
| 5 | Benzodiazepine [EPC] | 11 |
| 6 | Estrogen [EPC] | 11 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 |
| 8 | Platinum-based Drug [EPC] | 10 |
| 9 | Thiazide Diuretic [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Vitamin D2 Analog [EPC] | 3 | 0.0004 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 4 | Aluminum Complex [EPC] | 6 | 0.0002 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 6 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 7 | Vitamin D Analog [EPC] | 3 | 0.0002 |
| 8 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 9 | Complement Inhibitor [EPC] | 7 | 0.0001 |